Skip to content

Boston Birth Cohort Study

Early Life Origins of Pediatric and Adult Diseases: Boston Birth Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03228875
Enrollment
24000
Registered
2017-07-25
Start date
1998-10-01
Completion date
2032-12-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Outcome, Adverse, Child Health, Maternal Health, Pregnancy Complications

Keywords

Boston Birth Cohort, Early life origins of pediatric and adult disease, Gene environment interaction, Health across life course and generations

Brief summary

Early life exposures may lead to adverse effects on health in later life. The Boston birth Cohort study is designed to study a broad array of early life factors and their effects on maternal and child health outcomes across the life course.

Detailed description

Any woman admitted to the Labor and Delivery floor at the Boston Medical Center (BMC) who delivers a singleton live infant and meets our case (gestational age \<37 weeks or birthweight \<2,500 grams) or control (full term birth with birthweight \>2,500 grams) criteria will be eligible. Postnatal follow-up of enrolled mother-child pair is conducted from birth to age 21 years. The Boston Birth Cohort has high-quality biospecimen collection, and comprehensive epidemiological, clinical, and environmental exposure data via standardized questionnaire interview, measurements, and review of the electronic medical records.

Interventions

None listed

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER
Boston Medical Center
CollaboratorOTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Mothers who deliver singleton live births at Boston Medical Center are eligible for the study.

Exclusion criteria

* pregnancies that are a result of in vitro fertilization or that involve multiple gestations, fetal chromosomal abnormalities or major birth defects.

Design outcomes

Primary

MeasureTime frameDescription
Participants with Pregnancy complications - including hypertensive disorders and gestational diabetesAt birthhypertensive disorders during pregnancy, gestational diabetes
Birth outcomes - number of participants with preterm birthsAt birthBirth outcomes are examined - preterm birth.
Birth outcomes - birth weight in grams (g)At birthBirth outcomes are examined - birth weight (g)
Child health outcomes - number of participants overweight or obeseFrom birth to 21 yearsoverweight or obesity
Maternal health outcomes - number of participants with maternal diabetesAfter delivery to 21 yearsmaternal diabetes
child health outcome - systolic and diastolic blood pressurefrom birth to 21 yearsblood pressure (mmHg)
child health outcome - participants with neuro-developmental disorders including autism and ADHDfrom birth to 21 yearsneuro-developmental disorders including autism and ADHD
child health outcome - number of participants with asthmafrom birth to 21 yearsasthma

Countries

United States

Contacts

CONTACTXiaobin Wang, MD, ScD
xwang82@jhu.edu410-9555824
PRINCIPAL_INVESTIGATORXiaobin Wang, MD, ScD

Johns Hopkins Bloomberg School of Public Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026